ECMO (体外式膜型人工肺) システム市場 - 成長、動向、予測

ECMO (体外式膜型人工肺) システム、通称エクモ市場の成長には、心血管疾患および呼吸器疾患の増加、肺移植における採用の増加、ECMOセンターの増加、認知度を高めるための会議やトレーニングプログラムの増加、技術の進歩などが寄与していると考えられます。さらに、インドや中国のような人口の多い国では、高齢者人口や病気に苦しむ人の数が増加しており、ECMOシステムに大きな成長の機会を提供するでしょう。

当レポートでは、世界のECMO (体外式膜型人工肺) 市場を調査し、市場の概要、応用領域・モダリティ・地域別の市場動向、市場規模の推移と予測、市場シェア、市場促進・阻害要因ならびに市場機会・課題の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

• 調査成果
• 調査の前提条件
• 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

• 市場概要
• 市場成長要因
• 市場の抑制要因
• ポーターのファイブフォース分析
  • 新規参入の脅威
  • バイヤー/消費者の交渉力
  • サプライヤーの交渉力
  • 代替製品の脅威
  • 競争の激化

第5章 市場細分化

• モダリティ別
  • 静脈動脈（VA）
  • 静脈静脈（VV）
  • その他
• 応用別
  • 呼吸器疾患
  • 心疾患
  • 体外心肺蘇生法（ECPR）
• 地域別
  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ地域
  • 南米

第6章 競合情勢

• 企業プロファイル
  • Alung Technologies Inc.
  • Eurosets
  • Getinge AB
  • Livanova Plc
  • Medtronic
  • Microport Scientific Corporation
  • Nipro Medical Corporation
  • Terumo Medical Corporation
  • Thoratec Corporation
  • Xenios AG

第7章 市場機会および将来動向

The growth of the extracorporeal membrane oxygenation (ECMO) system market can be contributed to the growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to lung transplantation, growing number of ECMO centers, conferences & training programs to increase awareness, and technological advancements. In addition, the rising geriatric population and the number of people suffering from diseases in populous countries such as India & China are factors that are expected to offer significant growth opportunities for ECMO systems.

However, complications associated with extracorporeal membrane oxygenation machine such as bleeding, infections, and technical failures; along with high cost and lack of skilled professionals is a challenge to the market.

Key Market Trends

Respiratory Applications is expected to Dominate the Market

Asthma is one of the major noncommunicable diseases. It is a chronic disease of the air passages of the lungs which inflames and narrows them. According to a World Health Organization 2017 report, there are approximately 235 million people suffering from asthma globally. As per this report, there were 383,000 deaths due to asthma in 2015. Moreover, the prevalence of asthma seems to be increasing at a rapid pace.

As per the Center for Disease Control and Prevention (CDC) 2016 report, the prevalence of asthma among adults aged 20 and over increased from 7.1% in 2009-2010 to 9.2% in 2013-2014. Therefore ECMO is useful as to provide adequate gas exchange and prevent lung injury induced by mechanical ventilation. This is very helpful for asthama patients.

As a result, the use of ECMO in cases of near-fatal asthma (NFA) has increased over the years, as per a report by Hye Ju Yeo et al., published in Critical care Journal 2017. Hence all these factors are expected to help the market growth.

North America is Expected to Dominate the Market

As per the American heart association, coronary heart disease is the leading cause of deaths (45.1%) attributable to the cardiovascular disease in the United States, followed by stroke (16.5 %) and heart failure (8.5 %). Moreover, about 5.7 million adults in the United States die of heart failure every year, of which the percentage of in-hospital failures holds a huge potential to be reduced by the usage of ECMO. COPD is the third-leading cause of death in the United States, with its prevalence increasing in direct correlation with changing demography. Although, non-invasive mechanical ventilation (NIV) is the primary prognosis, a shift has been observed, in recent years, toward ECMO (which is considered to be a more efficient alternative).

According to a recent article published in 2018, the use of extracorporeal membrane oxygenation (ECMO) has been exponentially increasing over the last decade and is now considered as a mainstream lifesaving treatment modality in critical care medicine.

Hence, the survival rates for adults with severe acute respiratory failure treated with ECMO have also improved dramatically over the past 30 years. These factors are expected to help the market grow in the region.

Competitive Landscape

Majority of the extra corporeal membrane oxygenation system are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:

• The market estimate (ME) sheet in Excel format
• Report customization as per the client's requirements
• 3 months of analyst support

Table of Contents

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Prevalence of Cardiovascular and Respiratory Diseases
  • 4.2.2 Technological Advancements in ECMO Technology
  • 4.2.3 Increased Adoption of ECMO Systems
• 4.3 Market Restraints
  • 4.3.1 High Cost of ECMO Procedures
  • 4.3.2 Risks Associated with ECMO System
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Modality
  • 5.1.1 Veno-Arterial (VA)
  • 5.1.2 Veno-Venous (VV)
  • 5.1.3 Others
• 5.2 By Application
  • 5.2.1 Respiratory Applications
  • 5.2.2 Cardiac Applications
  • 5.2.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Alung Technologies Inc.
  • 6.1.2 Eurosets
  • 6.1.3 Getinge AB
  • 6.1.4 Livanova Plc
  • 6.1.5 Medtronic
  • 6.1.6 Microport Scientific Corporation
  • 6.1.7 Nipro Medical Corporation
  • 6.1.8 Terumo Medical Corporation
  • 6.1.9 Thoratec Corporation
  • 6.1.10 Xenios AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS